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Objective: To determine the prevalence of diabetic retinopathy among patients attending the 
diabetic clinics of a tertiary hospital in Nigeria.
Methodology: We examined the eyes of 76 patients with type 2 diabetes mellitus between 
July 2003 and January 2004 using dilated fundoscopy at the eye clinic of the University College 
Hospital, Ibadan. The results were compared with published ﬁ  gures.
Results: Mean age of patients was 57.5 ± 10.4 years. Thirty–two patients (42.1%) had diabetic 
retinopathy. Of these, one patient had features of proliferative diabetic retinopathy while the 
other patients had non-proliferative diabetic retinopathy. Majority (53.1%) of those who had 
retinopathy had diabetes for more than 10 years, while 21.4% of patients without retinopathy 
had diabetes for more than 10 years (p = 0.005). The mean serial post-prandial plasma glucose 
of those who had retinopathy was higher when compared with the mean for those who did not 
have retinopathy (248.7 mg/dl vs 178.3 mg/dl; p = 0.003).
Conclusion: The prevalence of diabetic retinopathy in our patients is higher than was previously 
reported in earlier studies. Patients with diabetes ought to be referred for ophthalmological 
evaluation and follow-up which they should be actively encouraged to attend.
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Introduction
Diabetes mellitus is an important health problem worldwide. In Africans, there has been 
a progressive increase in the prevalence of diabetes mellitus and the burden is expected 
to increase even further (Adeleye et al 2006). Due to the high urban growth rate, dietary 
changes, reduction in physical activity, and increasing incidence of obesity, it is estimated 
that the prevalence of diabetes may triple within the next 25 years (Sobngwi et al 2001).
Diabetic retinopathy is the leading cause of blindness in adults between the ages 
of 20 and 65 in industrialized countries (Rotimi et al 2003). It is said to account 
for 12% of new cases of blindness in the USA (Patz and Smith 1991; Moss et al 
1998) and 11.9% of all blind registration in those aged 16–64 years in the United 
Kingdom (Evans et al 1996). Population based surveys in developed countries have 
reported the presence of retinopathy in about a third of adults with diabetes; 36.8% 
(Klein et al 1992a), 32.4% (Mitchell et al 1998). Over thirty years ago, diabetic 
retinopathy was reported to be rare in Nigerians (Osuntokun 1969; Abiose 1978). 
But more recent studies have shown that the occurrence of diabetic retinopathy in 
Nigeria is on the increase (Erasmus et al 1989), and that it accounts for 16.7% of all 
retinal diseases (Nwosu 2000). Other studies report prevalence rates between 15% 
and 38% among clinic attending diabetics patients in Sub Saharan Africa (Erasmus 
et al 1989; Kalk et al 1997; Ndiaye et al 1999; Nwosu 2000; Seyoum et al 2001; 
Rotimi et al 2003).Clinical Ophthalmology 2008:2(1) 104
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Certain factors have been well documented as being 
signiﬁ  cantly associated with an increased risk of development 
and/or worsening of diabetic retinopathy. These include 
duration of diabetes (Klein et al 1992b), age (Krakoff et al 
2003), female sex (Sparrow 1993), poor blood sugar control 
ie, hyperglycemia (Stratton et al 2001), elevated blood 
pressure (Matthews et al 2004), hyperlipidemia (Viswanath 
2003), diabetic nephropathy (El-Asrar et al 2001; Trevisan 
et al 2002; Alebiosu et al 2003) and obesity (Van Leiden 
et al 2002; Katusic et al 2005).
Racial differences in the risk of developing retinopathy 
exist among individuals with type 2 diabetes (Harris et al 
1998; Leske et al 1999). These differences may be due to 
increased risk of diabetes in the black population (Harris 
1991; Cooper et al 1997) or increased prevalence of risk 
factors for diabetic retinopathy among black patients 
or a greater impact of identiﬁ  ed risk factors for diabetic 
retinopathy among them.
Differences in the prevalence of diabetic retinopathy 
between African Americans and whites have been explained 
by differences in diabetic severity, glycaemic control and 
presence of elevated blood pressure (Harris et al 1998; 
Leske et al 1999). Longitudinal studies are needed to 
address these issues; and data presented will be useful to 
establish prevention in the high risk groups. West Africans 
who share the same ancestry origin as African Americans 
are such high risk groups. This pilot study was conducted 
to provide estimates for use in sample size calculations in 
subsequent work. The study was a collaborated study of 
patients with type 2 diabetes mellitus conducted with the 
aim of investigating the laboratory and clinical parameters 
of diabetes as well as to determine the prevalence of diabetic 
retinopathy among new patients attending the diabetic clinics 
of the hospital.
Patients and methods
The study population was drawn from the adults with diabetes 
who attended the diabetic clinic of the University College 
Hospital (UCH), Ibadan.
All consecutive new patients with type 2 diabetes seen 
at the diabetic clinic between July 2003 and January 2004 
were referred to the eye clinic of the same hospital. Patients 
were classiﬁ  ed as having type 2 diabetes mellitus if they did 
not require insulin to achieve glycaemic control within the 
ﬁ  rst 3 months of diagnosis as well as if they were older than 
20 years of age.
Retinopathy status was assessed using dilated ophthal-
moscopy by an experienced ophthalmologist who had no 
prior knowledge of the clinical characteristics of the patients, 
thereby eliminating clinical potential sources of bias. No 
fundus photography was available at the time of the study.
Information was obtained with the use of a structured 
questionnaire. Other data collected included demographic 
data, history of co-morbid illness, complications of diabetes, 
and compliance with current medication. Investigations per-
formed at the diabetic clinic included serial monthly fasting 
plasma glucose and two hour post-prandial plasma glucose, 
urinalysis, Glomerular ﬁ  ltration rate estimation, and renal 
ultrasound scan. In the absence of facilities for measurement 
of Hemoglobin A1c, which is a better indicator of glucose 
control over time, all plasma glucose results of the preced-
ing three to six months of all subjects were averaged. All 
estimations were carried out in the central laboratory of the 
hospital. This variable gave a fairly accurate indication of the 
level of control of plasma glucose in these patients.
Ocular examination comprised of refraction, pen torch 
and slit lamp examination as well as dilated fundoscopy with 
the use of 78D Volk lens. A diagnosis of diabetic retinopathy 
was made only where a participant had a minimum of one 
microaneurysm in any ﬁ  eld, as well as exhibiting hemor-
rhages (dot, blot, or ﬂ  ame shaped), and maculopathy (with 
or without clinically signiﬁ  cant edema). Proliferative diabetic 
retinopathy was diagnosed when there was neovascularisa-
tion. The criteria used to classify patients into categories of 
diabetic retinopathy was based on the criteria of the Diabetic 
Retinopathy Study (DRS Report 7 1981) and Early Treatment 
Diabetic Retinopathy Study (ETDRS Report 10 1991).
Approval for the study protocol was obtained from 
the Institutional Ethical Review Board of the College of 
Medicine, University of Ibadan. Informed consent was 
obtained from each participant at the clinic.
Data collected at both the diabetic clinic and the eye clinic 
was analyzed using SPSS version 11 software. Statistical 
signiﬁ  cance was p   0.05.
Although both eyes were examined, the eye with the more 
severe retinopathy was used for analysis.
Results
Out of the 133 patients recruited into study at the diabetic 
clinics, 76 patients (57.1%) presented at the eye clinic for 
ocular examination. These 76 patients were studied.
There were 37 males and 39 females (male to female 
ratio – 0.95). Their ages ranged between 33 and 82 years 
with a mean of 57.5 ± 10.4 years.
Duration since diagnosis of diabetes mellitus ranged from 
three months to 30 years with a mean of 8.6 ± 7.6 years.Clinical Ophthalmology 2008:2(1) 105
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Forty-seven patients (61.8%) were on treatment for 
hypertension.
Therapy for control of diabetes was by dietary control 
in 1 patient (1.3%); the use of oral hypoglycaemic agents in 
68 patients (89.5%) and insulin in 7 patients (9.2%).
The clinical and laboratory characteristics of those who 
participated in the ocular assessment were similar to those 
who did not turn up for examination.
Males constituted 48.7% of participants compared 
with 56.1% of non-participants (p = 0.3). The mean age of 
participants was 57.5 years compared with 56.1 years for non-
participants (p = 0.5). The comparison of the characteristics 
of the two groups is shown in Table 1.
Two of the patients examined at the eye clinic were found 
to have bilateral lens opacities dense enough to prevent 
a satisfactory view of the posterior pole and therefore a 
deﬁ  nite statement on the presence or absence of retinopathy 
could not be made. These two patients were not included in 
further analysis.
Of the remaining 74 patients, 32 (42.1%) had diabetic 
retinopathy. One (3.1%) of these patients had features of 
proliferative diabetic retinopathy while 31 patients (96.9%) 
had non-proliferative diabetic retinopathy.
The mean age of patients with retinopathy was higher than 
the mean age of those patients without retinopathy (57.8 years 
vs 56.9 years; p = 0.7). The mean duration since diagnosis 
(of diabetes) in patients who had retinopathy was longer 
than the mean for those without retinopathy (11.1 years vs 
6.6 years; p = 0.01). The mean post-prandial plasma glucose 
(calculated from three to six months of serial monitoring) of 
those who had retinopathy was higher when compared with 
the mean for those who did not have retinopathy (248.7 mg/dl 
vs 178.3 mg/dl; p = 0.003). Table 2 shows the comparison 
of the mean values of the various parameters studied in the 
two groups of patients.
Further analysis revealed that 74.2% of those with 
retinopathy were older than 50 years, compared to 64.3% 
of the patients without retinopathy that were older than 
50 years (p = 0.37). Females made up 56.3% of those with 
retinopathy compared to 50% of those without retinopathy 
(p = 0.6).
Majority (53.1%) of the patients with retinopathy had 
diabetes for more than 10 years, compared to 21.4% of 
those without retinopathy (p = 0.005; Odds ratio = 2.5; 95% 
Conﬁ  dence Interval = 1.3–4.8).
A larger proportion of those with diabetic retinopathy 
had poor glycemic control ie, post-prandial plasma glucose 
greater than 200 mg/dl in comparison with those without 
retinopathy (58.3% vs 27.0%; p = 0.014; Odds ratio = 2.2; 
95% Conﬁ  dence interval = 1.2–4.0).
In addition, 18.8% of those with retinopathy were on 
insulin therapy while 2.4% of those without retinopathy 
were on insulin (p = 0.02; Odds ratio = 7.7; 95% conﬁ  dence 
interval = 0.97–60.7) Table 3 shows other factors that were 
compared between the two groups.
Discussion
The response rate of the patients referred for ophthalmological 
examination was poor with only 57% of the patients actually 
presenting to the eye clinic. This is a manifestation of the lack 
of importance attached to routine eye examinations by diabetic 
patients seen at UCH Ibadan. Adequate health education for 
newly diagnosed diabetic patients is imperative in order to 
emphasize the need for regular eye examinations.
The patients who were examined do not differ from 
those who did not participate with respect to the major 
Table 1 Characteristics by participation status
 Participants  Non-participants  p  value
n 76    57  –
Male sex (%)  48.7  56.1  0.3
Mean age (years)  57.5(±10.4) 56.1(±14.3) 0.5
Mean duration (years)  8.6(±7.6) 8.1(±7.2) 0.7
Insulin therapy (%)  9.3  19.3  0.1
Mean serial plasma glucose (mg/dL)  207.4(±93.0) 189.2(±70.0) 0.2
Mean body mass index (kg/m2) 25.99(±4.8) 25.85(±4.3) 0.9
Mean systolic blood pressure (mmHg)  137.2(±20.8) 135.2(±27.8) 0.7
Mean diastolic blood pressure (mmHg)  82.8(±12.1) 82.0(±11.8) 0.7
Presence of albuminuria (%)  28.6  48.6  0.07
Mean estimated GFRa (mL/min)  82.2(±23.6) 79.6(±28.4) 0.6
Abbreviation: aGFR, Glomerular Filtration rate.Clinical Ophthalmology 2008:2(1) 106
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study parameters. Although the proportion of females, 
patients on insulin therapy and those who had albuminuria 
as well as the mean serial post-prandial plasma glucose was 
higher in the participants group, there was no statistically 
signiﬁ  cant difference. Hence the possibility of selection 
bias is minimized and is not likely to account for the poor 
response rate observed.
The prevalence of diabetic retinopathy among these 
patients (42.1%) is higher than has been reported elsewhere 
in Nigeria and West Africa. Erasmus et al (1989) reported 
a prevalence of 15.1% among the 377 diabetic patients 
they studied in a Nigerian Teaching Hospital, while Rotimi 
et al (2003) working on a group of 840 diabetic patients in 
Nigerian and Ghanian tertiary hospitals reported that 17.9% 
of them had retinopathy. Thus, it may be postulated that the 
prevalence of retinopathy among diabetics in Nigeria is on 
the increase however the difference in number of patients 
studied may be responsible for the higher prevalence 
recorded in this study. Another factor that may account 
for the differences in prevalence is the variation in criteria 
for deﬁ  ning the presence of diabetic retinopathy between 
different studies. In addition, variations in the examiners 
(ophthalmologist vs non-ophthalmologist) as well as the 
examination methods (direct vs indirect ophthalmoloscopy) 
should be considered. The use of the Volk lens increases the 
sensitivity of fundoscopy in diagnosis of retinal lesions.
The duration of diabetes was signiﬁ  cantly associated 
with the presence of diabetic retinopathy. This risk factor 
has been described as the most important and strongest risk 
factor associated with development of diabetic retinopathy 
(Klein et al 1992b). We found that those patients who had the 
disease for more than 10 years since diagnosis were two and a 
half times more likely to have diabetic retinopathy than those 
whose disease was diagnosed less than 10 years previously. 
This ﬁ  nding is in concordance with various studies that have 
established the fact that longer duration of diabetes increases 
the risk of microvascular complications (Klein et al 1992b; 
Porta et al 2002; Williams et al 2004).
Elevated mean serial post-prandial plasma glucose 
level was also signiﬁ  cantly associated with an increased 
risk of having retinopathy in the patients we studied. Our 
ﬁ  nding simply corroborates a well established fact that poor 
control of hyperglycemia increases the risk of development 
and progression of the complications of diabetes mellitus 
including retinopathy (Stratton et al 2001; Schellhase et al 
2005).
Table 2 Study factors by retinopathy status
  No retinopathy  Have retinopathy  p value
N 42  32 
Mean age (years)  56.9(±10.8) 57.8(±9.8) 0.7
Mean duration (years)  6.6(±6.8) 11.1(±8.1) 0.01
Mean serial plasma glucose (mg/dL)  178.3(±83.9) 248.7(±88.7) 0.003
Mean body mass index (kg/m2) 26.1(±4.5) 25.9(±5.2) 0.9
Mean systolic blood pressure (mmHg)  136.2(±18.3) 138.5(±23.9) 0.7
Mean diastolic blood pressure (mmHg)  82.1(±10.4) 84.6(±14.0) 0.23
Mean estimated GFRa (mL/min)  86.4(±38.4) 76.8(±26.4) 0.32
Abbreviation: aGFR, Glomerular Filtration rate.
Table 3 Study factors by retinopathy status
 No  retinopathy  Have  retinopathy  p  value
N 42  32 
Age   50 yrs  64.3%  74.2%  0.37
Female sex  50%  56.3%  0.6
Duration   10 yrs  21.4%  53.1%  0.005
Insulin therapy  2.4%  18.8%  0.02
Mean serial plasma glucose   200 mg/dl  27.0%  58.3%  0.014
Body mass index   25 kg/m2 59.5%  48.4%  0.4
Systolic blood pressure   130 mmHg  51.3%  58.1%  0.6
Diastolic blood pressure   80 mmHg  43.6%  61.3%  0.1
Presence of albuminuria  31.3%  20.0%  0.5
Estimated GFRa   60 mL/min  43.8%  43.8%  0.95
Abbreviation: aGFR, Glomerular Filtration rate.Clinical Ophthalmology 2008:2(1) 107
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We also found that the type of medication used 
signiﬁ  cantly inﬂ  uenced the risk of diabetic retinopathy in 
the patients studied. Speciﬁ  cally, the use of insulin was 
associated with a seven-fold increase in the risk of having 
retinopathy.
A reason for this ﬁ  nding which has also been reported in 
other studies (Klein 1987) is that use of insulin therapy in 
Type 2 diabetics is an indication of severity of the disease. 
And it is well established that the risk of retinopathy is higher 
in patients with more severe diabetes mellitus. However, 
making any conclusion from this ﬁ  nding is limited by the 
small number of patients on insulin therapy.
Other factors studied were found not to be signiﬁ  cantly 
associated with occurrence of retinopathy. These include 
age, body mass index, blood pressure, albuminuria, and 
estimated GFR values. These factors, especially albuminuria 
and decreased GFR which are related to diabetic nephropathy 
have been well established as being associated with the risk of 
retinopathy (Trevisan et al 2002). However, our observation 
may be due to the relatively small number of patients studied 
which is one of the limitations of the study.
Other limitations of the study include the poor response 
rate, the lack of Hemoglobin A1c measurements and the lack 
of fundus photography.
In conclusion, the prevalence of diabetic retinopathy in 
our patients is higher than was previously reported in earlier 
studies. Patients’ awareness of the need for eye examination 
appears low and as such newly diagnosed diabetics should be 
encouraged to attend regular ophthalmological examinations 
to enable early detection and treatment of retinopathy as well 
as other microvascular complications of diabetes especially 
diabetic nephropathy. This intervention is important 
preliminary to further studies.
References
Abiose A. 1978. Retinal diseases in Nigeria – a preliminary report. Niger 
Med J, 6:180–3.
Adeleye JO, Agada NO, Balogun WO, et al. 2006. Diabetes care in Nigeria: 
time for a paradigm shift. Afr J Med Med Sci, 35:155–9.
Alebiosu CO, Odusan O, Jaiyesimi A. 2003. Morbidity in relation to stage 
of diabetic nephropathy in type-2 diabetic patients. J Natl Med Assoc, 
95:1042–7.
Cooper RS, Rotimi CN, Kaufman JS, et al. 1997. Prevalence of NIDDM 
among populations of the African Diaspora. Diabetes Care, 
20:343–8.
Diabetic Retinopathy Study Research Group. 1981. A modiﬁ  cation of the 
Airlie House Classiﬁ  cation of Diabetic Retinopathy Report 7. Invest 
Ophthalmol Vis Sci, 21:210–26.
Early Treatment Diabetic Retinopathy Study Research Group. 1991. Grading 
diabetic retinopathy from stereoscopic color fundus photographs – an 
extension of the modiﬁ  ed Airlie House Classiﬁ  cation. ETDRS Report 
Number 10. Ophthalmology, 98:807–22.
El-Asrar AM, Al-Rubeaan KA, Al-Amro SA, et al. 2001. Retinopathy 
as a predictor of other diabetic complications. Int Opthalmol, 
24:1–11.
Erasmus RT, Alanamu RA, Bojuwoye B, et al. 1989. Diabetic retinopathy 
in Nigerians: relation to duration of diabetes, type of treatment and 
degree of control. East Afr Med J, 66:248–54.
Evans J, Rooney C, Ashwood F, et al. 1996. Blindness and partial sight 
in England and Wales: April 1990–March 1991. Health Trends, 
28:5–12.
Harris MI. 1991. Epidemiological correlates of NIDDM in Hispanics, whites, 
and blacks in the U.S. population. Diabetes Care, 14:639–48.
Harris MI, Klein R, Cowie CC, et al. 1998. Is the risk of diabetic retinopathy 
greater in non-Hispanic blacks and Mexican Americans than in non- 
Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes 
Care, 21:1230–5.
Kalk WJ, Joannou J, Ntsepo S, et al. 1997. Ethnic differences in the clinical 
and laboratory associations with retinopathy in adult onset diabetes: 
studies in patients of African, European and Indian origins. J Intern 
Med, 241:31–7.
Katusic D, Tomic M, Jukic T, et al. 2005. Obesity – a risk factor for 
diabetic retinopathy in type 2 diabetes?. Coll Antropol, 29 (Suppl 
1):47–50.
Klein R. 1987. The epidemiology of diabetic retinopathy: findings 
from the Wisconsin Epidemiologic Study of Diabetic Retinopathy. 
Int Ophthalmol Clin, 27:230–8.
Klein R, Klein BEK, Moss SE, et al. 1992a. The Beaver Dam Eye Study. 
Retinopathy in adults with newly discovered and previously diagnosed 
diabetes mellitus. Ophthalmology, 99:58–62.
Klein R, Klein BE, Moss SE. 1992b. Epidemiology of proliferative diabetic 
retinopathy. Diabetes Care, 15:1875–91.
Krakoff J, Lindsay RS, Looker HC, et al. 2003. Incidence of retinopathy and 
nephropathy in youth-onset compared with adult-onset type 2 diabetes. 
Diabetes Care, 26:76–81.
Leske MC, Wu SY, Hyman L. 1999. Diabetic retinopathy in a black 
population:the Barbados Eye Study. Ophthalmology, 106:1893–9.
Matthews DR, Stratton IM, Aldington SJ, et al. 2004. UK Prospective 
Diabetes Study Group Risks of progression of retinopathy and vision 
loss related to tight blood pressure control in type 2 diabetes mellitus: 
UKPDS 69. Arch Ophthalmol, 122:1631–40.
Mitchell P, Smith W, Wang JJ, et al. 1998. Prevalence of diabetic retinopathy 
in an older communityThe Blue Mountains Eye Study. Ophthalmology, 
105:406–11.
Moss SE, Klien R, Klien BEK. 1998. The 14 year incidence of visual loss 
in a diabetic population. Ophthalmology, 105:998–1003.
Ndiaye MR, Cisse A, De Medeiros M, et al. 1999. Prevalence of diabetic 
retinopathy at the Dakar University Hospital Center. Dakar Med, 
44:158–61.
Nwosu SNN. 2000. Prevalence and pattern of retinal disease at the Guinness 
Eye Hospital, Onitsha, Nigeria. Ophthalmic Epidemiol, 7:41–8.
Osuntokun BO. 1969. Diabetic retinopathy in Nigerians. Br J Ophthalmol, 
53:652.
Patz A, Smith RE. 1991. The ETDRS and Diabetes 2000 (Editorial). 
Ophthalmology, 98:739–40.
Porta M, Bandello F. 2002. Diabetic retinopathy A clinical update. 
Diabetologia, 45:1617–34.
Rotimi C, Daniel H, Zhou J, et al. 2003. Prevalence and determinants of 
diabetic retinopathy and cataracts in West African type 2 diabetes 
patients. Ethn Dis, 13(2 Suppl 2):S110–7.
Schellhase KG, Koepsell TD, Weiss NS. 2005. Glycemic control and 
the risk of multiple microvascular diabetic complications. Fam Med, 
37:125–30.
Seyoum B, Mengistu Z, Berhanu P, et al. 2001. Retinopathy in 
patients of Tikur Anbessa Hospital diabetic clinic. Ethiop Med J, 
39:123–31.
Sobngwi E, Mauvais-Jarvis F, Vexiau P, et al. 2001. Diabetes in Africans. 
Part 1: Epidemiology and clinical speciﬁ  cations. Diabetes Metab, 
27:628–34.Clinical Ophthalmology 2008:2(1) 108
Ashaye et al
Sparrow JM, McLeod BK, Smith TD, et al. 1993. The prevalence of 
diabetic retinopathy and maculopathy and their risk factors in the non-
insulintreated diabetic patients of an English town. Eye, 7:158–63.
Stratton IM, Kohner EM, Aldington SJ, et al. 2001. UKPDS 50: risk factors 
for incidence and progression of retinopathy in Type II diabetes over 6 
years from diagnosis. Diabetologia, 44:156–63.
Trevisan R, Vedovato M, Mazzon C, et al. 2002. Concomitance of diabetic 
retinopathy and proteinuria accelerates the rate of decline of kidney 
function in type 2 diabetic patients. Diabetes Care, 25:2026–31.
Van Leiden HA, Dekker JM, Moll AC. 2002. Blood pressure, lipids and 
obesity are associated with retinopathy: the horn study. Diabetes Care, 
25:1320–5.
Viswanath K, Murray McGavin DD. 2003. Diabetic retinopathy: clinical 
ﬁ  ndings and management. J Comm Eye Health, 16:21–4.
Williams R, Airey M, Baxter H, et al. 2004. Epidemiology of diabetic reti-
nopathy and macular oedema: a systematic review. Eye, 18:963–83.